GO:0160317 endolysosomal intralumenal vesicle membrane: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160317 defines the lipid bilayer that surrounds an intraluminal vesicle (ILV) inside an endolysosome, a key membrane of the multivesicular endosome system.
• ILV membranes are formed by inward budding of the endosomal limiting membrane, a process driven by ESCRT complexes and regulated by accessory proteins such as Lgd.
• The ILV membrane is enriched in bis(monoacylglycero)phosphate (BMP), a phospholipid that regulates membrane fusion and is linked to lysosomal storage disorders and LRRK2 biology.
• Proteins such as Caveolin-1 can be ubiquitinated and sorted to ILVs for degradation, demonstrating the ILV membrane as a site of protein quality control.
• Pathogens including Anaplasma phagocytophilum exploit multivesicular body biogenesis and ILV membranes for proliferation and dissemination.
• Disruption of endolysosomal trafficking and ILV membrane dynamics alters exosome production, with implications for glioblastoma and other cancers.
Description
The endolysosomal intralumenal vesicle membrane (GO:0160317) is the lipid bilayer that encloses an intraluminal vesicle (ILV) within an endolysosome. This membrane is a defining structural feature of multivesicular endosomes (MVEs), which are endosomal compartments that contain numerous internal vesicles formed by inward budding of the limiting membrane. The ILV membrane is not a passive barrier; it is a specialized lipid and protein environment that controls cargo sorting, degradation, and extracellular vesicle release. Understanding this membrane is essential for researchers studying endosomal sorting, lysosomal biology, and extracellular vesicle biogenesis. ILV membranes are dynamically formed and consumed. They originate from the endosomal limiting membrane through ESCRT-dependent and ESCRT-independent mechanisms, and they are ultimately delivered to lysosomes for degradation or released as exosomes upon fusion of MVEs with the plasma membrane. The lipid composition of the ILV membrane, particularly its enrichment in bis(monoacylglycero)phosphate (BMP), distinguishes it from the limiting membrane and creates a unique platform for protein-lipid interactions. This distinct composition is critical for membrane fusion events and for the sorting of specific cargoes, including ubiquitinated proteins like Caveolin-1. Dysregulation of ILV membrane dynamics is linked to a range of human diseases, including lysosomal storage disorders, neurodegeneration, and cancer. For example, mutations in LRRK2 and glucocerebrosidase affect BMP release via extracellular vesicles, connecting ILV membrane biology to Parkinson's disease and Gaucher disease. In cancer, compounds that disrupt endolysosomal trafficking stimulate exosome production from glioblastoma cells, highlighting the ILV membrane as a therapeutic target. This article provides a research-grade overview of GO:0160317, covering its definition, structure, molecular mechanisms, key genes, disease relevance, and experimental methods for study.
endolysosomal intralumenal vesicle membrane At A Glance
| GO ID | GO:0160317 |
|---|---|
| GO term | endolysosomal intralumenal vesicle membrane |
| Ontology | cellular_component |
| Synonym | endolysosome ILV membrane, endolysosome internal vesicle membrane |
| Major function | Forms the lipid bilayer of intraluminal vesicles within endolysosomes, serving as a platform for cargo sorting, degradation, and extracellular vesicle release. |
| Related cellular component | Multivesicular endosome, endolysosome, intraluminal vesicle |
| Key lipids | Bis(monoacylglycero)phosphate (BMP), a phospholipid enriched in ILV membranes |
| Key proteins | ESCRT complexes, Lgd, Caveolin-1, LRRK2, glucocerebrosidase |
| Associated processes | Endosomal sorting, multivesicular body biogenesis, exosome secretion, lysosomal degradation |
What Is GO:0160317?
GO:0160317, endolysosomal intralumenal vesicle membrane, is defined by QuickGO as the lipid bilayer surrounding an intraluminal vesicle within an endolysosome. In other words, it is the membrane that encloses the small internal vesicles found inside endolysosomes, which are formed by inward budding of the endosomal limiting membrane. This membrane separates the interior of the ILV from the lumen of the endolysosome and is characterized by a unique lipid and protein composition that supports cargo sorting and degradation.
Why Is endolysosomal intralumenal vesicle membrane Important in Cell Biology?
The endolysosomal intralumenal vesicle membrane is important because it is the central structural and functional platform for endosomal sorting and degradation, and its dysfunction is linked to major human diseases including lysosomal storage disorders, neurodegeneration, and cancer. It controls the fate of receptors, lipids, and proteins, and it is the origin of exosomes, which are key mediators of intercellular communication. Understanding this membrane at the molecular level is therefore essential for both basic cell biology and translational research.
• It is the membrane that defines intraluminal vesicles, which are essential for sorting and degrading ubiquitinated membrane proteins such as Caveolin-1.
• It is enriched in bis(monoacylglycero)phosphate (BMP), a lipid that regulates membrane fusion and is implicated in lysosomal storage disorders and Parkinson's disease.
• It is the site of ESCRT-III complex assembly and regulation by Lgd, which controls intraluminal vesicle formation.
• It is exploited by pathogens such as Anaplasma phagocytophilum for proliferation and dissemination.
• It is the source of exosomes, which are extracellular vesicles that mediate intercellular communication in cancer and neurodegeneration.
• Its dysfunction is associated with lysosomal storage disorders, as shown by proteome landscapes in induced neurons from patients.
• It is a target for compounds that disrupt endolysosomal trafficking and stimulate exosome production in glioblastoma cells.
• It is a key component of the multivesicular endosome system, which is central to endosomal maturation and cargo sorting.
• It is involved in the regulation of LRRK2 and glucocerebrosidase activity, linking it to Parkinson's disease.
• It provides a platform for studying membrane dynamics, lipid-protein interactions, and vesicle trafficking.
What Happens During endolysosomal intralumenal vesicle membrane?
Initiation of intraluminal vesicle budding
In simple terms: The endosomal membrane starts to bend inward to form a small vesicle.
Intraluminal vesicle (ILV) formation begins with the inward budding of the endosomal limiting membrane, a process that requires the coordinated action of ESCRT complexes and accessory proteins. The ESCRT-0, -I, and -II complexes recognize ubiquitinated cargo and recruit ESCRT-III, which drives membrane deformation and scission. Lgd regulates ESCRT-III complex accumulation at multivesicular endosomes to control ILV formation, ensuring proper vesicle size and number. This step is critical for sorting cargo into the ILV membrane and lumen.
Cargo sorting and membrane composition
In simple terms: Proteins and lipids are selected to go into the small vesicle.
During ILV formation, specific cargoes are sorted into the invaginating membrane. Ubiquitinated proteins, such as Caveolin-1, are targeted to ILVs for degradation. The ILV membrane is enriched in bis(monoacylglycero)phosphate (BMP), a phospholipid that is not present in the limiting membrane and that regulates membrane fusion and protein sorting. This unique lipid composition is essential for the recruitment of specific proteins and for the subsequent fate of the ILV.
Vesicle scission and release into the lumen
In simple terms: The small vesicle pinches off and floats inside the endosome.
After budding, the ILV is released into the endosomal lumen through a scission event that requires ESCRT-III and its associated ATPase VPS4. The resulting ILV membrane faces the cytosol with its original orientation, but its lipid and protein composition is distinct from the limiting membrane. This step is regulated by Lgd and other factors that control ESCRT-III disassembly. The ILV membrane is now a stable structure within the endolysosome.
Fusion with lysosomes and degradation
In simple terms: The endosome merges with a lysosome, and the small vesicles are broken down.
Mature multivesicular endosomes fuse with lysosomes, delivering ILVs to the lysosomal lumen for degradation. The ILV membrane is degraded by lysosomal lipases and proteases, and its cargo is broken down into basic components. This process is essential for protein quality control and membrane homeostasis. Defects in this step lead to accumulation of undegraded material, as seen in lysosomal storage disorders.
Release as exosomes
In simple terms: Instead of being degraded, the small vesicles can be released outside the cell.
Alternatively, multivesicular endosomes can fuse with the plasma membrane, releasing ILVs as exosomes. The ILV membrane becomes the exosome membrane, and its composition reflects the sorting events that occurred during ILV formation. This pathway is exploited by cancer cells, such as glioblastoma, where disruption of endolysosomal trafficking stimulates exosome production. Exosomes carry BMP and other lipids, and their release is regulated by LRRK2 and glucocerebrosidase.
Key Genes Involved in GO:0160317 endolysosomal intralumenal vesicle membrane
The following genes and proteins are key players in the biogenesis, regulation, and function of the endolysosomal intralumenal vesicle membrane.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ESCRT-0 (HGS, STAM) | Recognizes ubiquitinated cargo and initiates ILV budding | Core machinery for ILV formation; knockout studies reveal cargo sorting defects |
| ESCRT-I (TSG101, VPS28) | Recruits ESCRT-II and concentrates cargo | Essential for MVE biogenesis; knockdown blocks ILV formation |
| ESCRT-II (VPS25, VPS36) | Induces membrane curvature and recruits ESCRT-III | Mutations affect ILV morphology and sorting |
| ESCRT-III (CHMP4, CHMP2) | Drives membrane scission and ILV release | Regulated by Lgd; key for vesicle scission |
| VPS4 | ATPase that disassembles ESCRT-III | Required for ILV formation and recycling of ESCRT components |
| Lgd | Regulates ESCRT-III accumulation at MVEs | Controls ILV formation; loss leads to enlarged MVEs |
| Caveolin-1 | Ubiquitinated cargo targeted to ILVs for degradation | Model for studying ILV-mediated protein degradation |
| LRRK2 | Regulates BMP release via extracellular vesicles | Implicated in Parkinson's disease; affects ILV membrane lipid composition |
| GBA (glucocerebrosidase) | Regulates BMP release and lysosomal function | Mutations cause Gaucher disease and increase Parkinson's risk |
| BMP (lipid) | Major phospholipid of ILV membrane | Regulates membrane fusion and sorting; linked to lysosomal storage disorders |
| Anaplasma phagocytophilum effectors | Exploit MVB biogenesis for proliferation | Pathogen strategy to hijack ILV membranes |
| Rab7 | Regulates MVE fusion with lysosomes | Controls ILV degradation; mutations affect endolysosomal trafficking |
| Rab27a | Regulates MVE fusion with plasma membrane | Controls exosome secretion; affects ILV membrane release |
| SNARE proteins (VAMP7, Syntaxin-7) | Mediate membrane fusion events | Required for ILV delivery to lysosomes and exosome release |
| Alix (PDCD6IP) | ESCRT accessory protein involved in ILV formation | Regulates cargo sorting and exosome biogenesis |
| TSG101 | ESCRT-I component | Commonly used as marker for MVE and ILV studies |
| CD63 | Tetraspanin enriched on ILV membranes | Marker for exosomes and ILVs; used in imaging |
How Is endolysosomal intralumenal vesicle membrane Regulated?
The formation and function of the endolysosomal intralumenal vesicle membrane are regulated at multiple levels. ESCRT-III assembly and disassembly are controlled by Lgd, which ensures proper accumulation of ESCRT-III at multivesicular endosomes. Lipid composition, particularly the presence of bis(monoacylglycero)phosphate (BMP), regulates membrane fusion and protein sorting, and BMP release is modulated by LRRK2 and glucocerebrosidase activity. Additionally, Rab GTPases such as Rab7 and Rab27a control the fusion of MVEs with lysosomes or the plasma membrane, thereby determining whether ILVs are degraded or released as exosomes. These regulatory mechanisms are critical for maintaining cellular homeostasis and are disrupted in various diseases.
endolysosomal intralumenal vesicle membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GBA | Gaucher disease, Parkinson's disease | Knockout or point mutation in induced pluripotent stem cells differentiated to neurons |
| LRRK2 | Parkinson's disease | Knock-in of G2019S mutation in dopaminergic neurons |
| Caveolin-1 | Protein degradation defects, cancer | Knockout in HeLa or glioblastoma cells to study ILV sorting |
| Lgd | Developmental defects, MVE biogenesis | Knockout in Drosophila or mammalian cells |
| Anaplasma phagocytophilum effectors | Anaplasmosis | Infection of host cells with knockout of MVB genes |
Lysosomal storage disorders and neurodegeneration
Mutations in genes that regulate ILV membrane dynamics, such as GBA and LRRK2, are linked to lysosomal storage disorders and Parkinson's disease. Proteomic studies in induced neurons from patients with lysosomal storage disorders reveal widespread changes in endolysosomal proteins, highlighting the importance of ILV membrane integrity. BMP, a key lipid of the ILV membrane, accumulates in these disorders and contributes to disease pathology.
Cancer and exosome-mediated communication
In glioblastoma, compounds that disrupt endolysosomal trafficking stimulate exosome production, suggesting that ILV membrane dynamics influence tumor progression and intercellular communication. Exosomes released from cancer cells carry oncogenic cargo and can remodel the tumor microenvironment. Targeting ILV membrane biogenesis may therefore be a therapeutic strategy in cancer.
Infectious diseases
The obligate intracellular pathogen Anaplasma phagocytophilum exploits host cell multivesicular body biogenesis for proliferation and dissemination. By hijacking ILV membrane formation, the pathogen creates a favorable niche for replication. This highlights the ILV membrane as a target for antimicrobial strategies.
From endolysosomal intralumenal vesicle membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the role of ESCRT-III in ILV membrane scission? | Knockout of CHMP4 or CHMP2 in HeLa cells |
| How does Lgd regulate ESCRT-III accumulation? | Knockout or knockdown of Lgd in Drosophila or mammalian cells |
| What is the fate of ubiquitinated Caveolin-1 in ILVs? | Point mutation of ubiquitination sites in Caveolin-1 followed by imaging |
| How does BMP regulate membrane fusion? | Knockout of BMP synthase or addition of exogenous BMP in liposome assays |
| What is the impact of LRRK2 mutation on BMP release? | Knock-in of LRRK2 G2019S in induced neurons |
| How does Anaplasma exploit MVB biogenesis? | Infection of host cells with ESCRT knockdown |
How to Study the endolysosomal intralumenal vesicle membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Electron microscopy | ILV morphology, size, and number | Visualizing ILV membranes in endolysosomes |
| Immuno-EM | Localization of specific proteins on ILV membranes | Identifying ESCRT components on ILVs |
| Fluorescence microscopy | Dynamic tracking of ILV markers | Live-cell imaging of CD63-GFP |
| Proteomics | Protein composition of ILV membranes | Identifying novel ILV-associated proteins |
| Lipidomics | Lipid composition, including BMP | Quantifying BMP in ILV membranes |
| Exosome isolation | Release of ILVs as exosomes | Studying exosome production in cancer |
| Ubiquitination assays | Sorting of ubiquitinated cargo to ILVs | Tracking Caveolin-1 degradation |
| iPSC-derived neurons | Disease-related changes in ILV dynamics | Modeling lysosomal storage disorders |
Imaging of ILV membranes
Electron microscopy (EM) is the gold standard for visualizing ILV membranes within endolysosomes, revealing their size, number, and morphology. Immuno-EM with gold-labeled antibodies against CD63 or ESCRT components can localize specific proteins to ILV membranes. Fluorescence microscopy with markers such as GFP-CD63 allows live-cell tracking of ILV dynamics.
Proteomics and lipidomics
Mass spectrometry-based proteomics of isolated ILVs can identify the protein composition of the ILV membrane. Lipidomics is essential for quantifying BMP and other lipids enriched in ILV membranes. These approaches have been used to study lysosomal storage disorders and LRRK2-related changes.
Genetic and biochemical assays
Knockout or knockdown of ESCRT components, Lgd, or Rab GTPases followed by biochemical fractionation can assess ILV formation and cargo sorting. Ubiquitination assays and pulse-chase experiments track the degradation of ILV-targeted proteins like Caveolin-1. Exosome isolation and characterization quantify ILV release.
Functional studies in disease models
Induced pluripotent stem cell (iPSC)-derived neurons from patients with lysosomal storage disorders provide a platform to study ILV membrane dysfunction. Glioblastoma cell lines treated with vacuole-inducing compounds reveal changes in exosome production. Infection models with Anaplasma phagocytophilum elucidate pathogen exploitation of ILV membranes.
How CRISPR Can Be Used to Study GO:0160317 endolysosomal intralumenal vesicle membrane
Knockout
CRISPR knockout of ESCRT components (e.g., TSG101, CHMP4) or Lgd can abolish ILV formation, leading to enlarged endosomes and defective cargo sorting. Knockout of GBA or LRRK2 in iPSCs or cell lines models lysosomal storage disorders and Parkinson's disease, revealing changes in BMP release and ILV membrane composition. These models are essential for dissecting the core machinery of ILV biogenesis.
Point Mutation
Point mutations in LRRK2 (e.g., G2019S) or GBA (e.g., N370S) can be introduced using CRISPR to study their effects on ILV membrane dynamics and BMP release. Mutating ubiquitination sites in Caveolin-1 prevents its sorting to ILVs, allowing researchers to map the sorting signals. Point mutations in ESCRT-III subunits can disrupt membrane scission without affecting complex assembly.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) into endogenous ILV marker genes such as CD63 or TSG101 enables real-time imaging of ILV membranes in live cells. Knock-in of disease-associated mutations (e.g., LRRK2 G2019S) in iPSCs provides isogenic models for studying ILV membrane dysfunction. These models are valuable for high-content screening and dynamic studies.
Overexpression
Overexpression of ESCRT components or Lgd can increase ILV formation and alter exosome release. Overexpression of BMP synthase enzymes can elevate BMP levels in ILV membranes, affecting membrane fusion. Overexpression of Caveolin-1 mutants can saturate the ILV sorting pathway, revealing rate-limiting steps.
How EDITGENE Supports endolysosomal intralumenal vesicle membrane Research
Researchers studying endolysosomal intralumenal vesicle membrane-related genes often need to determine whether a candidate gene is causally involved in ILV biogenesis, cargo sorting, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of GO:0160317.
Contact EDITGENE today to design your custom CRISPR model for endolysosomal intralumenal vesicle membrane research.
Frequently Asked Questions About endolysosomal intralumenal vesicle membrane
What is the endolysosomal intralumenal vesicle membrane?
It is the lipid bilayer surrounding an intraluminal vesicle within an endolysosome, defined by GO:0160317.
What genes are involved in endolysosomal intralumenal vesicle membrane formation?
Key genes include ESCRT components (TSG101, CHMP4), Lgd, Caveolin-1, LRRK2, and GBA.
What is the function of intraluminal vesicles?
They sort and degrade ubiquitinated proteins and can be released as exosomes for intercellular communication.
How is the endolysosomal intralumenal vesicle membrane formed?
It forms by inward budding of the endosomal limiting membrane, driven by ESCRT complexes and regulated by Lgd.
What lipids are enriched in the endolysosomal intralumenal vesicle membrane?
Bis(monoacylglycero)phosphate (BMP) is a major phospholipid enriched in ILV membranes.
What diseases are associated with endolysosomal intralumenal vesicle membrane dysfunction?
Lysosomal storage disorders, Parkinson's disease, cancer, and infections like anaplasmosis.
How can I study the endolysosomal intralumenal vesicle membrane?
Use electron microscopy, proteomics, lipidomics, and CRISPR knockout models.
What is the role of LRRK2 in the endolysosomal intralumenal vesicle membrane?
LRRK2 regulates BMP release via extracellular vesicles, linking ILV membrane biology to Parkinson's disease.
Can pathogens exploit the endolysosomal intralumenal vesicle membrane?
Yes, Anaplasma phagocytophilum exploits multivesicular body biogenesis for proliferation.
What CRISPR models are available for studying the endolysosomal intralumenal vesicle membrane?
Knockout, point mutation, knock-in, and overexpression models for ESCRT, Lgd, GBA, LRRK2, and other genes.
Conclusion
The endolysosomal intralumenal vesicle membrane (GO:0160317) is a specialized lipid bilayer that is central to endosomal sorting, degradation, and exosome release. Its unique composition, particularly enrichment in BMP, and its regulation by ESCRT complexes and accessory proteins make it a critical hub for cellular homeostasis. Dysregulation of this membrane is linked to lysosomal storage disorders, neurodegeneration, cancer, and infectious diseases. Continued research using advanced CRISPR models and multi-omics approaches will further illuminate its roles and therapeutic potential.
References
- 1. Gruenberg J. 2020. Life in the lumen: The multivesicular endosome.. Traffic 21(1):76-93 PMID: 31854087
- 2. Meneses-Salas E et al.. 2026. Extracellular vesicle-mediated release of bis(monoacylglycerol)phosphate is regulated by LRRK2 and glucocerebrosidase activity.. Elife 14 PMID: 41925724
- 3. Clarke AL et al.. 2022. Lgd regulates ESCRT-III complex accumulation at multivesicular endosomes to control intralumenal vesicle formation.. Mol Biol Cell 33(14):ar144 PMID: 36287829
- 4. Kraus F et al.. 2026. A human lysosomal storage disorder toolkit for decoding proteome landscapes in cortical-like and dopaminergic-like induced neurons.. Proc Natl Acad Sci U S A 123(27):e2609132123 PMID: 42384675
- 5. Hayer A et al.. 2010. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation.. J Cell Biol 191(3):615-29 PMID: 21041450
- 6. Mannsverk S et al.. 2022. Influenza Virus Membrane Fusion Is Promoted by the Endosome-Resident Phospholipid Bis(monoacylglycero)phosphate.. J Phys Chem B 126(49):10445-10451 PMID: 36468619
- 7. Read CB et al.. 2022. The Obligate Intracellular Bacterial Pathogen Anaplasma phagocytophilum Exploits Host Cell Multivesicular Body Biogenesis for Proliferation and Dissemination.. mBio 13(6):e0296122 PMID: 36409075
- 8. Li Z et al.. 2018. Vacuole-inducing compounds that disrupt endolysosomal trafficking stimulate production of exosomes by glioblastoma cells.. Mol Cell Biochem 439(1-2):1-9 PMID: 28770472
